Key Highlights
•
A new gene therapy approach using a virus to deliver targeted microRNAs successfully reduced the expression of a harmful retroviral protein linked to ALS in mice, slowing the loss of motor neurons and improving their movement. This provides a promising new strategy for treating forms of ALS that are connected to this specific viral protein, moving beyond just managing symptoms.
Source →
•
A real-world study of the Alzheimer’s drug lecanemab in Chinese patients showed it effectively slowed cognitive decline and was well-tolerated, with side effects like brain swelling occurring in less than 10% of participants. Importantly, a simple blood test measuring a protein called p‑tau217 strongly correlated with the drug’s effectiveness, offering a potential easy way to monitor treatment response.
Source →
•
Researchers identified a specific deficiency in a gene called OGFRL1 as a novel cause of a painful, recurring bone inflammation in children known as chronic recurrent multifocal osteomyelitis (CRMO). The patient with this genetic flaw responded exceptionally well to a common anti-inflammatory drug (a TNF inhibitor), pinpointing a new treatment target for this hard-to-manage condition.
Source →
•
A study of over 11,000 women found that while labor generally progresses faster in women who have had more children, a significant subgroup of women with five or more children showed delayed labor patterns similar to first-time mothers after their water broke at term. This finding challenges the assumption that all high-parity labors are fast and suggests doctors should use more individualized timing for interventions.
Source →
•
A specific type of small RNA fragment derived from transfer RNA (tRNA) has been identified as having a different expression pattern in babies with necrotizing enterocolitis, a severe intestinal disease common in premature infants. Discovering these RNA biomarkers could lead to new tools for early diagnosis or reveal novel pathways involved in the development of this life-threatening condition.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
